Skip to main content

Hannah Musick

News
02/11/2025
A research review in JCO Oncology Practice explores organizational strategies to combat rising oncologist burnout and emphasizes the importance of measuring and researching workforce wellness for a healthy work environment.
A research review in JCO Oncology Practice explores organizational strategies to combat rising oncologist burnout and emphasizes the importance of measuring and researching workforce wellness for a healthy work environment.
A research review in JCO...
02/11/2025
Integrated Healthcare Executive
News
02/10/2025
The use of ruxolitinib cream for atopic dermatitis shows promise in decreasing the need for other treatments, with reductions in oral corticosteroid use observed in some patients.
The use of ruxolitinib cream for atopic dermatitis shows promise in decreasing the need for other treatments, with reductions in oral corticosteroid use observed in some patients.
The use of ruxolitinib cream for...
02/10/2025
First Report Managed Care
News
02/07/2025
A new study shows promising potential of FDA-approved vaccines in preventing respiratory syncytial virus (RSV) in older adults, with Pfizer's RSVpreF offering the greatest health benefits and cost savings.
A new study shows promising potential of FDA-approved vaccines in preventing respiratory syncytial virus (RSV) in older adults, with Pfizer's RSVpreF offering the greatest health benefits and cost savings.
A new study shows promising...
02/07/2025
Pharmacy Learning Network
News
02/07/2025
A real-world study shows high indications of efficacy and safety of dacomitinib as a first-line treatment for EGFR-mutant NSCLC, with high response rate and median progression-free survival of 16.7 months, making it a valuable option for...
A real-world study shows high indications of efficacy and safety of dacomitinib as a first-line treatment for EGFR-mutant NSCLC, with high response rate and median progression-free survival of 16.7 months, making it a valuable option for...
A real-world study shows high...
02/07/2025
Journal of Clinical Pathways
News
02/06/2025
A comparison of infliximab brands Inflectra and Remsima in patients with Crohn's disease and ulcerative colitis reveals differences in post-induction levels and response rates, suggesting potential considerations for dosing adjustments based...
A comparison of infliximab brands Inflectra and Remsima in patients with Crohn's disease and ulcerative colitis reveals differences in post-induction levels and response rates, suggesting potential considerations for dosing adjustments based...
A comparison of infliximab...
02/06/2025
First Report Managed Care
News
02/06/2025
A scoping review in the Journal of Interprofessional Care investigates the challenges of interprofessional collaboration in primary and allied health care, emphasizing the necessity of new funding models to enhance teamwork and coordination...
A scoping review in the Journal of Interprofessional Care investigates the challenges of interprofessional collaboration in primary and allied health care, emphasizing the necessity of new funding models to enhance teamwork and coordination...
A scoping review in the Journal...
02/06/2025
Integrated Healthcare Executive
News
02/06/2025
A cost-effectiveness analysis suggests that dostarlimab plus carboplatin-paclitaxel may be a valuable first-line treatment option for patients with primary advanced or recurrent endometrial cancer.
A cost-effectiveness analysis suggests that dostarlimab plus carboplatin-paclitaxel may be a valuable first-line treatment option for patients with primary advanced or recurrent endometrial cancer.
A cost-effectiveness analysis...
02/06/2025
First Report Managed Care
News
02/05/2025
This study identifies key barriers to care for patients with GI cancers, leading to the development of an equity-focused intervention to improve care delivery and address disparities in treatment.
This study identifies key barriers to care for patients with GI cancers, leading to the development of an equity-focused intervention to improve care delivery and address disparities in treatment.
This study identifies key...
02/05/2025
Journal of Clinical Pathways
Conference Coverage
02/03/2025
Gain insights on navigating the future of neurological therapies from industry experts at the 2025 NeuroNet Pro Annual Summit.
Gain insights on navigating the future of neurological therapies from industry experts at the 2025 NeuroNet Pro Annual Summit.
Gain insights on navigating the...
02/03/2025
First Report Managed Care
Conference Coverage
02/03/2025
Panelists at the 2025 NeuroNet Pro Annual Summit delve into the transformative power of artificial intelligence (AI) and collective clinical data in neurology, showcasing how partnerships and advanced technology are reshaping the landscape of...
Panelists at the 2025 NeuroNet Pro Annual Summit delve into the transformative power of artificial intelligence (AI) and collective clinical data in neurology, showcasing how partnerships and advanced technology are reshaping the landscape of...
Panelists at the 2025 NeuroNet...
02/03/2025
First Report Managed Care